Novan Therapeutics, a clinical stage biotechnology company focused on advancing innovation in dermatology via nitric oxide therapies, today announced that Kevin Barber, Ph.D., has been appointed to the newly created position of Vice President of Regulatory Affairs, effective immediately. Dr. Barber will direct Novan’s regulatory strategy as the primary interface with the FDA and will report directly to Dr. Nathan Stasko, Novan’s President.
Help employers find you! Check out all the jobs and post your resume.
